Login / Signup

Absolute lymphocyte count as a biomarker for best supportive care transition in metastatic breast cancer.

Yoshiya HorimotoHikari JimboYumiko IshizukaNoriko NogamiGoro KutomiJunichiro Watanabe
Published in: BMJ supportive & palliative care (2024)
Our data suggest that ALC values, which decrease as MBC progresses, could serve as a potential indicator for determining the optimal timing of BSC transition.
Keyphrases
  • metastatic breast cancer
  • peripheral blood
  • healthcare
  • palliative care
  • electronic health record
  • quality improvement
  • big data
  • pain management
  • human health
  • machine learning